Contera Pharma A/S

Contera Pharma identifies and develops innovative treatments for patients suffering from neurological disorders. Contera Pharma’s science is based on a precision medicine approach integrating external and internal data sources to support rational ID & selection of human disease-validated drug discovery targets to identify novel pipeline opportunities.

The company uses expertise in neuroscience drug discovery and development, in close collaboration with expert individuals and organizations, to accelerate R&D activities.

Contact name:

Anders Brandt Elvang


DTU Science Park, Agern Allé 24, 2970 Hørsholm, Denmark

Number of employees:


If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact or +45 7172 1114

Copyright 2011 DANISH BIO – DANSK BIOTEK. All rights reserved.